NASDAQ: FGEN - FibroGen

Yield per half year: -50.58%
Dividend yield: 0.00%
Sector: Нефтегаз

Share chart FibroGen

Extended chart Simple chart
Financial Markets by TradingView

About FibroGen

FibroGen, Inc.- научная фармацевтическая компания, специализирующаяся на открытии, разработке и коммерциализации новых терапевтических агентов для лечения серьезных медицинских заболеваний. Компания использует глобальный подход к разработке и коммерциализации своих продуктов.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2014-11-14
ISIN US31572Q8087
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.fibrogen.com
Цена ао 0.616
Change price per day: +0.5531% (0.5062)
Change price per week: -11.14% (0.5728)
Change price per month: +2.09% (0.4986)
Change price per 3 month: +65.26% (0.308)
Change price per half year: -50.58% (1.03)
Change price per year: -45.62% (0.936)
Change price per 3 year: -96.49% (14.52)
Change price per 5 year: -98.8% (42.42)
Change price per 10 year: -97.22% (18.34)
Change price per year to date: +19.85% (0.4247)
All parameters

Underestimation

Title Value Grade
P/S 12.58 1
P/BV -11.46 0
P/E 0 0
EV/EBITDA -7.39 0
Total: 3.38

Efficiency

Title Value Grade
ROA, % -67.11 0
ROE, % 139.22 10
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.3319 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -42.42 0
Yield Ebitda, % 254.21 10
Yield EPS, % 228.77 10
Total: 8
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
07.03.2024 11.03.2024 Wettig Thane
CEO		 Purchase 1.91 95 500 50000 0 0.05 link
04.08.2023 08.08.2023 Henderson Jeffrey William
Director		 Sale 1.91 3 820 2000 0 0 link
11.07.2023 13.07.2023 Henderson Jeffrey William
Director		 Sale 2.69 5 380 2000 0 0 link
07.07.2023 10.07.2023 Conterno Enrique A
Chief Executive Officer		 Sale 2.8 5 264 1880 0 0 link
09.06.2023 09.06.2023 EDWARDS JEFFREY L
Director		 Sale 17.19 135 612 7889 0 -0.01 link
09.06.2023 09.06.2023 Blaug Suzanne
Director		 Sale 17.2 146 544 8520 0 -0.01 link
08.06.2023 09.06.2023 Henderson Jeffrey William
Director		 Sale 17.46 122 220 7000 0 -0.01 link
08.06.2023 09.06.2023 Ho Maykin
Director		 Sale 17.44 148 589 8520 0 -0.01 link
07.06.2023 09.06.2023 Conterno Enrique A
Chief Executive Officer		 Sale 17.04 151 605 8897 0 -0.01 link
07.06.2023 09.06.2023 Eisner Mark
EVP, Chief Medical Officer		 Sale 17.04 34 796 2042 0 0 link
07.06.2023 09.06.2023 Chung Christine
SVP, China Operations		 Sale 17.04 61 906 3633 0 0 link
07.06.2023 09.06.2023 Graham Juan
Chief Financial Officer		 Sale 16.99 30 327 1785 0 0 link
07.06.2023 09.06.2023 Wettig Thane
Chief Commercial Officer		 Sale 17.04 29 956 1758 0 0 link
07.06.2023 09.06.2023 Schoeneck James A
Director		 Sale 18.03 128 013 7100 0 -0.01 link
23.03.2023 24.03.2023 Wettig Thane
Chief Commercial Officer		 Sale 18.71 16 933 905 0 0 link
23.12.2022 28.12.2022 Wettig Thane
Chief Commercial Officer		 Sale 15.8 11 597 734 0 0 link
15.06.2021 17.06.2021 Cotroneo Pat
SVP, Finance and CFO		 Sale 25.62 103 838 4053 0 0 link

Institutions Volume Share, %
PRIMECAP Management Company 14471928 14.65
Armistice Capital, LLC 9764000 9.89
Blackrock Inc. 7205300 7.29
Vanguard Group Inc 7044149 7.13
Jacobs Levy Equity Management, Inc. 2489506 2.52
Acadian Asset Management. LLC 2468928 2.5
Citadel Advisors Llc 2390681 2.42
Assenagon Asset Management S.A. 2226857 2.25
Two Sigma Investments, LP 2101283 2.13
Geode Capital Management, LLC 2018281 2.04

ETF Share, % Profitability for 1 year, % Dividends, %
ProShares UltraShort Nasdaq Biotechnology 0.47 -40.36 1.76
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.02077 12.46 3.59676
SPDR S&P Emerging Markets Small Cap ETF 0.01204 5.46 3.03583
iShares Micro-Cap ETF 0.01029 17.09 1.54048
Avantis Emerging Markets Value ETF 0.00067 14.12 4.22231
Vanguard FTSE All-World ex-US Small-Cap ETF 0 9.39 3.09932



Head Job title Payment Year of birth
Mr. Thane Wettig CEO & Director 807.35k 1965 (60 years)
Dr. Barry A. Berkowitz Ph.D. Founder N/A
Dr. John J. Hunter Ph.D. Chief Scientific Officer N/A 1963 (62 years)
Ms. Christine L. Chung Senior Vice President of China Operations 1.27M 1968 (57 years)
Mr. Michael D. Lowenstein J.D., Ph.D. Chief Legal Officer N/A
Ms. Tricia Stewart Chief People Officer N/A
Mr. Kirk A. Christoffersen MBA Chief Business Officer N/A 1969 (56 years)
Dr. Rahul Rajan Kaushik Ph.D. Senior Vice President of Pharmaceutical Development, Technical Operations & Manufacturing N/A
David DeLucia Vice President of Corporate FP&A and Investor Relations N/A
Mr. Juan Graham Senior VP & CFO 1976 (49 years)

Address: United States, San Francisco, CA , 409 Illinois Street - open in Google maps, open in Yandex maps
Website: https://www.fibrogen.com